| View |
BR-041-03
|
Enoxaparin Sodium
|
Enoxbicare-40
|
4000 IU Anti-Factor Xa (equivalent to 40 mg) / 0.4 mL
|
Solution For Injection (SC)
|
Brawn Laboratories Ltd.
|
India
|
-
|
25 April 2022
|
09 December 2025
|
| View |
BR-1000
|
Japanese Encephalitis Virus (Live, Attenuated)
|
Imojev
|
Formulation: After reconstitution, one dose (0.5 mL) contains 4.0-5.8 log Plaque Forming Units (PFU) live, attenuated, recombinant Japanese Encephalitis Virus.
|
Powder for Suspension for Injection (SC)
|
Government Pharmaceutical Organization - Merieux Biological Products Co., Ltd.
|
Thailand
|
Initial (Variation)
|
13 July 2022
|
13 July 2027
|
| View |
BR-1001
|
Phospholipid Fraction from Bovine Lung
|
Alveofact
|
45 mg/mL (54 mg/1.2 mL)
|
Lyophilized Powder for
Suspension for Intratracheal Administration
|
BAG Health Care GmbH
|
Germany
|
-
|
11 May 2021
|
06 January 2025
|
| View |
BR-1008
|
Human Insulin (Rdna)
|
Actrapid
|
100 IU/mL
|
Solution For Injection (Im/Iv/Sc)
|
Novo Nordisk A/S
|
Denmark
|
-
|
14 May 2020
|
06 May 2024
|
| View |
BR-1009
|
Insulin Human
|
Insulatard Flexpen
|
100 U/mL
|
Suspension For Injection (SC)
|
Novo Nordisk A/S
|
Denmark
|
-
|
08 March 2021
|
13 August 2025
|
| View |
BR-1010
|
Human Isophane Insulin
|
Insulatard
|
100 IU/mL
|
Suspension For Injection
|
Novo Nordisk A/S
|
Denmark
|
-
|
28 December 2018
|
20 August 2023
|
| View |
BR-1011
|
Insulin Detemir
|
Levemir FlexPen
|
100 U/ mL
|
Solution for injection
|
Novo Nordisk A/S
|
Denmark
|
Automatic Renewal
|
03 February 2022
|
22 December 2026
|
| View |
BR-1012
|
Insulin Human
|
Mixtard 30 FlexPen
|
100 IU/mL (Soluble Insulin 30% and Isophane Insulin 70%)
|
Suspension For Injection (SC)
|
Novo Nordisk A/S
|
Denmark
|
-
|
08 March 2021
|
25 August 2025
|
| View |
BR-1013
|
Somatropin
|
Norditropin SimpleXx
|
5 mg / 1.5 mL
|
Solution For Injection (SC)
|
Novo Nordisk A/S
|
Denmark
|
-
|
19 April 2021
|
15 November 2025
|
| View |
BR-1014
|
Biphasic Insulin Aspart 30
|
NovoMix 30 FlexPen
|
100 IU/ mL
|
Suspension for injection (SC)
|
Novo Nordisk A/S
|
Denmark
|
Automatic Renewal
|
01 February 2022
|
21 December 2026
|
| View |
BR-1015
|
Insulin Aspart
|
NovoRapid Flexpen
|
100 IU/ mL
|
Solution For Injection (SC)
|
Novo Nordisk A/S
|
Denmark
|
-
|
08 March 2021
|
13 August 2025
|
| View |
BR-1016
|
Liraglutide
|
Victoza
|
6mg/mL
|
Solution For Injection (SC)
|
Novo Nordisk A/S
|
Denmark
|
-
|
26 November 2021
|
07 February 2026
|
| View |
BR-1018
|
Darbepoetin Alfa
|
Nesp
|
20mcg/0.5mL
|
Solution For Injection (I.V. / S.C.)
|
Terumo Corporation (Kofu Factory)
|
Japan
|
-
|
09 October 2020
|
26 January 2025
|
| View |
BR-1019
|
Darbepoetin Alfa
|
Nesp
|
30mcg/0.5mL
|
Solution For Injection (I.V. / S.C.)
|
Terumo Corporation (Kofu Factory)
|
Japan
|
-
|
09 October 2020
|
26 January 2025
|
| View |
BR-1020
|
Darbepoetin Alfa
|
Nesp
|
40mcg/0.5mL
|
Solution For Injection (I.V./S.C.)
|
Terumo Corporation (Kofu Factory)
|
Japan
|
-
|
09 October 2020
|
26 January 2025
|
| View |
BR-1025
|
Tetanus Toxoid Adsorbed
|
None
|
40 iu / 0.5mL
|
Suspension for Injection (IM)
|
Biological E. Limited
|
India
|
-
|
06 March 2020
|
28 January 2025
|
| View |
BR-1026
|
Laronidase
|
Aldurazyme
|
580 mcg/mL (2.9 mg/5 mL)
|
Concentrated Solution for IV Infusion
|
Biomarin Pharmaceutical Inc.
|
U.S.A
|
-
|
22 March 2022
|
29 September 2026
|
| View |
BR-1027
|
Follitropin Beta
|
Puregon
|
300 I.U./ 0.36mL
|
Solution for Injection
|
Merck Sharp & Dohme B.V. Legal Entity N.V. Organon
|
Netherlands
|
-
|
25 May 2017
|
12 January 2022
|
| View |
BR-1029
|
Follitropin Beta
|
Puregon
|
50 I.U./ 0.5mL
|
Solution for Injection (IM/SC)
|
Merck Sharp & Dohme B.V. Legal Entity N.V. Organon
|
Netherlands
|
-
|
25 May 2017
|
23 February 2022
|
| View |
BR-1035
|
Interferon alfa 2b
|
Intron A
|
50 M IU/ mL
|
Solution for Injection (SC)
|
Schering-Plough (Ireland) Company T/A Schering-Plough (Brinny) Company
|
Ireland
|
-
|
10 October 2016
|
06 December 2020
|